Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2019

01-01-2019 | Original Article

Tropheryma whipplei Infection (Whipple Disease) in the USA

Authors: Isabel A. Hujoel, David H. Johnson, Benjamin Lebwohl, Daniel Leffler, Sonia Kupfer, Tsung-Teh Wu, Joseph A. Murray, Alberto Rubio-Tapia

Published in: Digestive Diseases and Sciences | Issue 1/2019

Login to get access

Abstract

Background

Whipple disease (WD) is an infection caused by the bacterium Tropheryma whipplei (TW). Few cases have been reported in the USA.

Aims

To report on the demographics, clinical manifestations, diagnostic findings, treatment, and outcomes of TW infection.

Methods

Cases of TW infection diagnosed from 1995 to 2010 were identified in three US referral centers and from 1995 to 2015 in one. Definite classic WD was defined by positive periodic acid-Schiff (PAS) staining and probable WD by specific positive TW polymerase chain reaction (PCR) of intestinal specimens. Localized infections were defined by a positive TW PCR result from samples of other tissues/body fluids.

Results

Among the 33 cases of TW infections, 27 (82%) were male. Median age at diagnosis was 53 years (range 11–75). Diagnosis was supported by a positive TW PCR in 29 (88%) and/or a positive PAS in 16 (48%) patients. Classic WD was the most frequent presentation (n = 18, 55%), with 14 definite and 4 probable cases. Localized infections (n = 15, 45%) affected the central nervous system (n = 7), joints (n = 4), heart (n = 2), eye (n = 1), and skeletal muscle (n = 1). Blood PCR was negative in 9 of 17 (53%) cases at diagnosis. Ceftriaxone intravenously followed by trimethoprim and sulfamethoxazole orally was the most common regimen (n = 23, 70%). Antibiotic therapy resulted in clinical response in 24 (73%).

Conclusions

TW infection can present as intestinal or localized disease. Negative small bowel PAS and PCR do not exclude the diagnosis of TW infection, and blood PCR is insensitive for active infection.
Literature
1.
go back to reference Paulley JW. Whipple’s disease, intestinal lipodystrophy. Gastroenterologia. 1949;75:32.PubMed Paulley JW. Whipple’s disease, intestinal lipodystrophy. Gastroenterologia. 1949;75:32.PubMed
2.
go back to reference Jones FA, Paulley JW. Intestinal lipodystrophy. Whipple’s disease. Lancet. 1949;1:214–217.CrossRef Jones FA, Paulley JW. Intestinal lipodystrophy. Whipple’s disease. Lancet. 1949;1:214–217.CrossRef
3.
go back to reference Dutly F, Altwegg M. Whipple’s disease and “Tropheryma whippelii”. Clin Microbiol Rev. 2001;14:561–583.CrossRef Dutly F, Altwegg M. Whipple’s disease and “Tropheryma whippelii”. Clin Microbiol Rev. 2001;14:561–583.CrossRef
4.
go back to reference Bai JC, Mazure RM, Vazquez H, et al. Whipple’s disease. Clin Gastroenterol Hepatol. 2004;2:849–860.CrossRef Bai JC, Mazure RM, Vazquez H, et al. Whipple’s disease. Clin Gastroenterol Hepatol. 2004;2:849–860.CrossRef
5.
go back to reference Paulley JW. A case of Whipple’s disease (intestinal lipodystrophy). Gastroenterology. 1952;22:128–133.PubMed Paulley JW. A case of Whipple’s disease (intestinal lipodystrophy). Gastroenterology. 1952;22:128–133.PubMed
6.
go back to reference Chears WC Jr, Ashworth CT. Electron microscopic study of the intestinal mucosa in Whipple’s disease. Demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology. 1961;41:129–138.PubMed Chears WC Jr, Ashworth CT. Electron microscopic study of the intestinal mucosa in Whipple’s disease. Demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology. 1961;41:129–138.PubMed
7.
go back to reference Feurle GE, Volk B, Waldherr R. Cerebral Whipple’s disease with negative jejunal histology. N Engl J Med. 1979;300:907–908.CrossRef Feurle GE, Volk B, Waldherr R. Cerebral Whipple’s disease with negative jejunal histology. N Engl J Med. 1979;300:907–908.CrossRef
8.
go back to reference Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple’s-disease-associated bacterium. Lancet. 1991;338:474–475.CrossRef Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple’s-disease-associated bacterium. Lancet. 1991;338:474–475.CrossRef
9.
go back to reference Dobbins WO 3rd. The diagnosis of Whipple’s disease. N Engl J Med. 1995;332:390–392.CrossRef Dobbins WO 3rd. The diagnosis of Whipple’s disease. N Engl J Med. 1995;332:390–392.CrossRef
10.
go back to reference Muller C, Stain C, Burghuber O. Tropheryma whippelii in peripheral blood mononuclear cells and cells of pleural effusion. Lancet. 1993;341:701.CrossRef Muller C, Stain C, Burghuber O. Tropheryma whippelii in peripheral blood mononuclear cells and cells of pleural effusion. Lancet. 1993;341:701.CrossRef
11.
go back to reference Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med. 1992;327:293–301.CrossRef Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med. 1992;327:293–301.CrossRef
12.
go back to reference Elkins C, Shuman TA, Pirolo JS. Cardiac Whipple’s disease without digestive symptoms. Ann Thorac Surg. 1999;67:250–251.CrossRef Elkins C, Shuman TA, Pirolo JS. Cardiac Whipple’s disease without digestive symptoms. Ann Thorac Surg. 1999;67:250–251.CrossRef
13.
go back to reference Greub G. A new piece added to the whipple puzzle: Tropheryma Whipplei primary infection with bacteremia and cough. Clin Infect Dis. 2010;51:522–524.CrossRef Greub G. A new piece added to the whipple puzzle: Tropheryma Whipplei primary infection with bacteremia and cough. Clin Infect Dis. 2010;51:522–524.CrossRef
14.
go back to reference Gabus V, Grenak-Degoumois Z, Jeanneret S, Rakotoarimanana R, Greub G, Genne D. Tropheryma whipplei tricuspid endocarditis: a case report and review of the literature. J Med Case Rep. 2010;4:245.CrossRef Gabus V, Grenak-Degoumois Z, Jeanneret S, Rakotoarimanana R, Greub G, Genne D. Tropheryma whipplei tricuspid endocarditis: a case report and review of the literature. J Med Case Rep. 2010;4:245.CrossRef
15.
go back to reference Ramzan NN, Loftus E Jr, Burgart LJ, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med. 1997;126:520–527.CrossRef Ramzan NN, Loftus E Jr, Burgart LJ, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med. 1997;126:520–527.CrossRef
16.
go back to reference Bruhlmann P, Michel BA, Altwegg M. Diagnosis and therapy monitoring of Whipple’s arthritis by polymerase chain reaction. Rheumatology (Oxford). 2000;39:1427–1428.CrossRef Bruhlmann P, Michel BA, Altwegg M. Diagnosis and therapy monitoring of Whipple’s arthritis by polymerase chain reaction. Rheumatology (Oxford). 2000;39:1427–1428.CrossRef
17.
go back to reference Fenollar F, Fournier P-E, Robert C, Raoult D. Use of Genome Selected Repeated Sequences Increases the Sensitivity of PCR Detection of Tropheryma whipplei. J Clin Microbiol. 2004;42:401–403.CrossRef Fenollar F, Fournier P-E, Robert C, Raoult D. Use of Genome Selected Repeated Sequences Increases the Sensitivity of PCR Detection of Tropheryma whipplei. J Clin Microbiol. 2004;42:401–403.CrossRef
18.
go back to reference Keita AK, Bassene H, Tall A, et al. Tropheryma whipplei: a common bacterium in rural Senegal. PLoS Negl Trop Dis. 2011;5:e1403.CrossRef Keita AK, Bassene H, Tall A, et al. Tropheryma whipplei: a common bacterium in rural Senegal. PLoS Negl Trop Dis. 2011;5:e1403.CrossRef
19.
go back to reference Li W, Fenollar F, Rolain JM, et al. Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology. 2008;154:521–527.CrossRef Li W, Fenollar F, Rolain JM, et al. Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology. 2008;154:521–527.CrossRef
20.
go back to reference Qin S, Clausen E, Lucht L, et al. Presence of Tropheryma whipplei in different body sites in a cohort of healthy subjects. Am J Respir Criti Care Med. 2016;194:243–245.CrossRef Qin S, Clausen E, Lucht L, et al. Presence of Tropheryma whipplei in different body sites in a cohort of healthy subjects. Am J Respir Criti Care Med. 2016;194:243–245.CrossRef
21.
go back to reference Martinetti M, Biagi F, Badulli C, et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology. 2009;136:2289–2294.CrossRef Martinetti M, Biagi F, Badulli C, et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology. 2009;136:2289–2294.CrossRef
22.
go back to reference Fleming JL, Wiesner RH, Shorter RG. Whipple’s disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63:539–551.CrossRef Fleming JL, Wiesner RH, Shorter RG. Whipple’s disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63:539–551.CrossRef
23.
go back to reference Desnues B, Al Moussawi K, Fenollar F. New insights into Whipple’s disease and Tropheryma whipplei infections. Microbes Infect. 2010;12:1102–1110.CrossRef Desnues B, Al Moussawi K, Fenollar F. New insights into Whipple’s disease and Tropheryma whipplei infections. Microbes Infect. 2010;12:1102–1110.CrossRef
24.
go back to reference Arnold CA, Moreira RK, Lam-Himlin D, De Petris G, Montgomery E. Whipple disease a century after the initial description: increased recognition of unusual presentations, autoimmune comorbidities, and therapy effects. Am J Surg Pathol. 2012;36:1066–1073.CrossRef Arnold CA, Moreira RK, Lam-Himlin D, De Petris G, Montgomery E. Whipple disease a century after the initial description: increased recognition of unusual presentations, autoimmune comorbidities, and therapy effects. Am J Surg Pathol. 2012;36:1066–1073.CrossRef
25.
go back to reference Fenollar F, Puechal X, Raoult D. Whipple’s disease. N Engl J Med. 2007;356:55–66.CrossRef Fenollar F, Puechal X, Raoult D. Whipple’s disease. N Engl J Med. 2007;356:55–66.CrossRef
26.
go back to reference Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 2010;89:337–345.CrossRef Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 2010;89:337–345.CrossRef
27.
go back to reference Fenollar F, Lagier JC, Raoult D. Tropheryma whipplei and Whipple’s disease. J Infect. 2014;69:103–112.CrossRef Fenollar F, Lagier JC, Raoult D. Tropheryma whipplei and Whipple’s disease. J Infect. 2014;69:103–112.CrossRef
28.
go back to reference Fenollar F, Raoult D. Whipple’s Disease. Clin Vaccin Immunol. 2001;8:1–8.CrossRef Fenollar F, Raoult D. Whipple’s Disease. Clin Vaccin Immunol. 2001;8:1–8.CrossRef
29.
go back to reference Dolmans R, Boel C, Lacle M, Kusters J. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev. 2017;30:529–555.CrossRef Dolmans R, Boel C, Lacle M, Kusters J. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev. 2017;30:529–555.CrossRef
30.
go back to reference Morgenegg S, Dutly F, Altwegg M. Cloning and sequencing of a part of the heat shock protein 65 gene (hsp65) of “Tropheryma whippleii” and its use for detection of “T. whippleii” in clinical specimens by PCR. J Clin Microbiol. 2000;38:2248–2253.PubMedPubMedCentral Morgenegg S, Dutly F, Altwegg M. Cloning and sequencing of a part of the heat shock protein 65 gene (hsp65) of “Tropheryma whippleii” and its use for detection of “T. whippleii” in clinical specimens by PCR. J Clin Microbiol. 2000;38:2248–2253.PubMedPubMedCentral
31.
go back to reference Feurle GE, Moos V, Schinnerling K, et al. The immune reconstitution inflammatory syndrome in whipple disease: a cohort study. Ann Intern Med. 2010;153:710–717.CrossRef Feurle GE, Moos V, Schinnerling K, et al. The immune reconstitution inflammatory syndrome in whipple disease: a cohort study. Ann Intern Med. 2010;153:710–717.CrossRef
32.
go back to reference Gunther U, Moos V, Offenmuller G, et al. Gastrointestinal diagnosis of classical whipple disease: clinical, endoscopic, and histophatologic features in 191 patients. Medicine (Baltimore). 2015;94:e714.CrossRef Gunther U, Moos V, Offenmuller G, et al. Gastrointestinal diagnosis of classical whipple disease: clinical, endoscopic, and histophatologic features in 191 patients. Medicine (Baltimore). 2015;94:e714.CrossRef
33.
go back to reference Muller SA, Vogt P, Altwegg M, Seebach JD. Deadly Carousel or difficult interpretation of new diagnostic tools for Whipple’s disease: case report and review of the literature. Infection. 2005;33:39–42.CrossRef Muller SA, Vogt P, Altwegg M, Seebach JD. Deadly Carousel or difficult interpretation of new diagnostic tools for Whipple’s disease: case report and review of the literature. Infection. 2005;33:39–42.CrossRef
34.
go back to reference Baisden BL, Lepidi H, Raoult D, Argani P, Yardley JH, Dumler JS. Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol. 2002;118:742–748.CrossRef Baisden BL, Lepidi H, Raoult D, Argani P, Yardley JH, Dumler JS. Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol. 2002;118:742–748.CrossRef
35.
go back to reference Edouard S, Fennolar F, Raoult D. The rise of Tropheryma whipplei: a 12-year retrospective study of PCR diagnoses in our reference center. J Clin Microbiol. 2012;50:3917–3920.CrossRef Edouard S, Fennolar F, Raoult D. The rise of Tropheryma whipplei: a 12-year retrospective study of PCR diagnoses in our reference center. J Clin Microbiol. 2012;50:3917–3920.CrossRef
36.
go back to reference Rolain J-M, Fenollar F, Raoult D. False positive PCR detection of Tropheryma whipplei in the saliva of healthy people. BMC Microbiol. 2007;7:48.CrossRef Rolain J-M, Fenollar F, Raoult D. False positive PCR detection of Tropheryma whipplei in the saliva of healthy people. BMC Microbiol. 2007;7:48.CrossRef
37.
go back to reference Fenollar F, Laouira S, Lepidi H, Rolain J-M, Raoult D. Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of whipple disease: usefulness of saliva and stool specimens for first-line screening. Clin Infect Dis. 2008;47:659–667.CrossRef Fenollar F, Laouira S, Lepidi H, Rolain J-M, Raoult D. Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of whipple disease: usefulness of saliva and stool specimens for first-line screening. Clin Infect Dis. 2008;47:659–667.CrossRef
38.
go back to reference Compain C, Sacre K, Puéchal X, et al. Central nervous system involvement in Whipple Disease: clinical study of 18 patients and long-term follow-up. Medicine (Baltimore). 2013;92:324–330. Compain C, Sacre K, Puéchal X, et al. Central nervous system involvement in Whipple Disease: clinical study of 18 patients and long-term follow-up. Medicine (Baltimore). 2013;92:324–330.
39.
go back to reference Keinath RD, Merrell DE, Vlietstra R, Dobbins WO 3rd. Antibiotic treatment and relapse in Whipple’s disease. Long-term follow-up of 88 patients. Gastroenterology. 1985;88:1867–1873.CrossRef Keinath RD, Merrell DE, Vlietstra R, Dobbins WO 3rd. Antibiotic treatment and relapse in Whipple’s disease. Long-term follow-up of 88 patients. Gastroenterology. 1985;88:1867–1873.CrossRef
40.
go back to reference Feurle GE, Marth T. An evaluation of antimicrobial treatment for Whipple’s Disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci. 1994;39:1642–1648.CrossRef Feurle GE, Marth T. An evaluation of antimicrobial treatment for Whipple’s Disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci. 1994;39:1642–1648.CrossRef
41.
go back to reference Ryser RJ, Locksley RM, Eng SC, Dobbins WO 3rd, Schoenknecht FD, Rubin CE. Reversal of dementia associated with Whipple’s disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier. Gastroenterology. 1984;86:745–752.PubMed Ryser RJ, Locksley RM, Eng SC, Dobbins WO 3rd, Schoenknecht FD, Rubin CE. Reversal of dementia associated with Whipple’s disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier. Gastroenterology. 1984;86:745–752.PubMed
42.
go back to reference Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease. Gastroenterology. 2010;138:478–486. quiz 411–472.CrossRef Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease. Gastroenterology. 2010;138:478–486. quiz 411–472.CrossRef
43.
go back to reference Lagier JC, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2014;69:219–227.CrossRef Lagier JC, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2014;69:219–227.CrossRef
44.
go back to reference Emonet S, Wuillemin T, Harbarth S, et al. Relapse of Tropheryma whipplei endocarditis treated by trimethoprim/sulfamethoxazole, cured by hydroxychloroquine plus doxycycline. Int J Infect Dis. 2015;30:17–19.CrossRef Emonet S, Wuillemin T, Harbarth S, et al. Relapse of Tropheryma whipplei endocarditis treated by trimethoprim/sulfamethoxazole, cured by hydroxychloroquine plus doxycycline. Int J Infect Dis. 2015;30:17–19.CrossRef
45.
go back to reference Fenollar F, Perreal C, Raoult D. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro. Int J Antimicrob Agents. 2014;43:388–390.CrossRef Fenollar F, Perreal C, Raoult D. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro. Int J Antimicrob Agents. 2014;43:388–390.CrossRef
46.
go back to reference Lagier JC, Fenollar F, Lepidi H, Raoult D. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple’s disease. J Antimicrob Chemother. 2010;65:2005–2012.CrossRef Lagier JC, Fenollar F, Lepidi H, Raoult D. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple’s disease. J Antimicrob Chemother. 2010;65:2005–2012.CrossRef
47.
go back to reference Boulos A, Rolain J-M, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents Chemother. 2004;48:747–752.CrossRef Boulos A, Rolain J-M, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents Chemother. 2004;48:747–752.CrossRef
48.
go back to reference Lagier JC, Fenollar F, Lepidi H, Raoult D. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple’s disease. J Antimicrob Chemother. 2011;66:1188–1189.CrossRef Lagier JC, Fenollar F, Lepidi H, Raoult D. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple’s disease. J Antimicrob Chemother. 2011;66:1188–1189.CrossRef
Metadata
Title
Tropheryma whipplei Infection (Whipple Disease) in the USA
Authors
Isabel A. Hujoel
David H. Johnson
Benjamin Lebwohl
Daniel Leffler
Sonia Kupfer
Tsung-Teh Wu
Joseph A. Murray
Alberto Rubio-Tapia
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5033-4

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.